Literature DB >> 20697979

Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.

Jun Dong1, Yaodong Zhao, Qiang Huang, Xifeng Fei, Yi Diao, Yuntian Shen, Hong Xiao, Tianyi Zhang, Qing Lan, Xiaosong Gu.   

Abstract

OBJECTIVE: Previous studies suggest that tumor cells might be the progenitor for tumor vasculature. Whether vascular tube formation from transdifferentiation of human glioma stem/progenitor cells (hGSPCs) contribute to angiogenesis of gliomas remain largely uncertain.
METHODS: hGSPCs were isolated from thirteen surgical specimens of gliomas and cultured in medium favored for stem cell growth. In vitro transdifferentiation of hGSPCs was performed under hypoxia. Expression of vascular endothelial cells (VECs) markers CD31, CD34, kinase insert domain receptor (KDR), and von Willebrand factor (vWF) were analyzed with real-time quantitative RT-PCR and immunofluorescence techniques. Vasculogenic mimicry of hGSPCs was evaluated in a tumor stem cell xenograft model in vivo. Relationships between content of hGSPCs and expression levels of both VECs markers and proangiogenic factors in large number of clinical specimens were further investigated in glioma tissue microarray.
RESULTS: In vitro, hGSPCs can transdifferentiate into VECs under hypoxia, they manifested typical "flagstone" pattern when cultivated in medium containing VEGF for a few days; when cultivated on Matrigel they were capable of forming capillary-like structures. Expression of VECs markers including CD31, CD34, KDR, and vWF were significantly up-regulated after transdifferentiation. Human leukocyte antigen (HLA) positively stained vessels were observed inside the xenograft tumors after intracerebral transplantation of hGSPCs in athymic nude mice, implied part of tumor cells with human origin were involved in formation of tumor vessels. In surgical specimens of human glioma, tumor vascular cells coexpressing the markers of early VECs (CD34) and markers of hGSPCs (ABCG2 and nestin) suggest that these vascular cells may stemmed from hGSPCs.
CONCLUSIONS: Our observations suggest the functional role of hGSPCs as endothelial progenitors, which have properties that give rise to VECs, and have the ability to form vascular endothelial tubes. However, unspecific markers (ABCG2, nestin) that stain for both endothelial as well as glioma stem cells, were found to be expressed in tumor vasculature of human specimen, and limit further interpretation of this finding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20697979     DOI: 10.1007/s12015-010-9169-7

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  43 in total

1.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

2.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

3.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors:  U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

Review 4.  ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.

Authors:  Brian L Abbott
Journal:  Clin Adv Hematol Oncol       Date:  2006-01

5.  Proliferation and differentiation of rat neuroepithelial precursor cells in vivo.

Authors:  K Frederiksen; R D McKay
Journal:  J Neurosci       Date:  1988-04       Impact factor: 6.167

6.  The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

Authors:  Christian W Scharenberg; Michael A Harkey; Beverly Torok-Storb
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

Review 7.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

8.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

9.  Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes.

Authors:  Chuzhao Lin; Richard McGough; Bassam Aswad; Joel A Block; Richard Terek
Journal:  J Orthop Res       Date:  2004-11       Impact factor: 3.494

Review 10.  Cancer stem cell: target for anti-cancer therapy.

Authors:  Carol Tang; Beng T Ang; Shazib Pervaiz
Journal:  FASEB J       Date:  2007-07-11       Impact factor: 5.191

View more
  32 in total

1.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

2.  Multiscale modeling of glioblastoma.

Authors:  Huaming Yan; Mónica Romero-López; Lesly I Benitez; Kaijun Di; Hermann B Frieboes; Christopher C W Hughes; Daniela A Bota; John S Lowengrub
Journal:  Transl Cancer Res       Date:  2018-02       Impact factor: 1.241

Review 3.  The P2X7 Receptor in the Maintenance of Cancer Stem Cells, Chemoresistance and Metastasis.

Authors:  Vanessa Fernandes Arnaud-Sampaio; Izadora Lorrany Alves Rabelo; Henning Ulrich; Claudiana Lameu
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

4.  Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.

Authors:  Shi-Yong Wang; Yi-Quan Ke; Guo-Hui Lu; Zhen-Hua Song; Li Yu; Sha Xiao; Xin-Lin Sun; Xiao-Dan Jiang; Zhi-Lin Yang; Chang-Chen Hu
Journal:  J Neurooncol       Date:  2013-02-16       Impact factor: 4.130

5.  Effect of doublecortin on self-renewal and differentiation in brain tumor stem cells.

Authors:  Manoranjan Santra; Sutapa Santra; Ben Buller; Kastuv Santra; Ankita Nallani; Michael Chopp
Journal:  Cancer Sci       Date:  2011-05-10       Impact factor: 6.716

Review 6.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Understanding melanoma stem cells.

Authors:  Nicholas Nguyen; Kasey L Couts; Yuchun Luo; Mayumi Fujita
Journal:  Melanoma Manag       Date:  2015

8.  Hitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche.

Authors:  Michael D Brooks; Rajarshi Sengupta; Steven C Snyder; Joshua B Rubin
Journal:  Curr Pathobiol Rep       Date:  2013-06-01

9.  Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.

Authors:  Donglai Lv; Lin Lu; Zongtao Hu; Zhenle Fei; Meiqin Liu; Lei Wei; Jun Xu
Journal:  Mol Neurobiol       Date:  2016-01-14       Impact factor: 5.590

Review 10.  Mechanisms of glioma-associated neovascularization.

Authors:  Matthew E Hardee; David Zagzag
Journal:  Am J Pathol       Date:  2012-08-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.